Fulton Breakefield Broenniman’s Mastercard MA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$280K Sell
546
-8
-1% -$3.99K 0.02% 167
2026
Q1
$277K Sell
554
-58
-9% -$30.5K 0.02% 157
2025
Q4
$349K Sell
612
-72
-11% -$40.2K 0.02% 146
2025
Q3
$389K Buy
684
+109
+19% +$62.6K 0.03% 143
2025
Q2
$323K Buy
575
+108
+23% +$59.7K 0.02% 153
2025
Q1
$256K Sell
467
-84
-15% -$45.7K 0.02% 154
2024
Q4
$290K Buy
551
+31
+6% +$16K 0.02% 149
2024
Q3
$257K Hold
520
0.02% 156
2024
Q2
$229K Buy
520
+1
+0.2% +$456 0.02% 172
2024
Q1
$250K Sell
519
-93
-15% -$42.5K 0.02% 162
2023
Q4
$261K Sell
612
-45
-7% -$18.1K 0.02% 150
2023
Q3
$260K Buy
657
+24
+4% +$9.63K 0.02% 151
2023
Q2
$249K Buy
633
+12
+2% +$4.5K 0.02% 158
2023
Q1
$226K Buy
+621
New +$226K 0.02% 164
2020
Q1
Sell
-801
Closed -$239K 170
2019
Q4
$239K Sell
801
-675
-46% -$190K 0.03% 166
2019
Q3
$401K Buy
+1,476
New +$407K 0.05% 118

Other funds holding MA

Fulton Breakefield Broenniman's MA Position: Q2 2026 in Review

Fulton Breakefield Broenniman reduced its Mastercard (MA) stake by 1.4% in Q2 2026, selling an estimated $3.99K and leaving 546 shares worth $280K. The position accounts for 0.02% of the portfolio, ranked #167.

Fulton Breakefield Broenniman first reported a position in MA in Q3 2019 and has held it in 16 quarters since. The position peaked at $401K in Q3 2019. 3,613 funds tracked by Wall St. Rank hold MA as of Q2 2026.

  • Fulton Breakefield Broenniman held 546 shares of Mastercard worth $280K as of Q2 2026.
  • Fulton Breakefield Broenniman sold 8 Mastercard shares in Q2 2026, an estimated $3.99K.
  • Mastercard made up 0.02% of Fulton Breakefield Broenniman's portfolio in Q2 2026, its #167 holding.
  • Fulton Breakefield Broenniman first reported a position in Mastercard in Q3 2019 and has held it in 16 quarters since.
  • Fulton Breakefield Broenniman's Mastercard position peaked at $401K in Q3 2019.
  • 3,613 funds tracked by Wall St. Rank held Mastercard as of Q2 2026.

Based on Fulton Breakefield Broenniman's 13F filing for Q2 2026, filed 3 Aug 2026.